Ira Fox
Impact in
- Pharmacology top 5%
- Treatment of Major Depression
- Psychiatry and Mental health top 5%
- Electroconvulsive Therapy Studies
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Treatment of Major Depression 7
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 5
- Mental Health Research Topics 1
- Co-authors
- Karl Rickels (8 shared papers)Edward E. Schweizer (6 shared papers)Cathryn M. Clary (4 shared papers)Charles C. Weise (3 shared papers)Jay D. Amsterdam (3 shared papers)Arthur P. Schless (1 shared paper)David J. Greenblatt (1 shared paper)Richard Balon (1 shared paper)
- Journals
- Pharmacopsychiatry (2 papers)Journal of Clinical Psychopharmacology (1 paper)Acta Psychiatrica Scandinavica (1 paper)American Journal of Psychiatry (1 paper)The British Journal of Psychiatry (1 paper)
- Partner nations
- United States
In The Last Decade
Ira Fox
8 papers receiving 420 citations
Peers
Comparison fields: 5 of 47
- Pharmacology 258
- Psychiatry and Mental health 157
- Experimental and Cognitive Psychology 144
- Biological Psychiatry 23
- Cellular and Molecular Neuroscience 82
Countries citing papers authored by Ira Fox
This map shows the geographic impact of Ira Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ira Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ira Fox more than expected).
Fields of papers citing papers by Ira Fox
This network shows the impact of papers produced by Ira Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ira Fox. The network helps show where Ira Fox may publish in the future.
Co-authors
The 10 scholars most cited alongside Ira Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 105 | |
| 2 | 1994 | 100 | |
| 3 | What constitutes an adequate antidepressant trial for fluoxetine? | 1990 | 85 |
| 4 | 1989 | 51 | |
| 5 | 1988 | 45 | |
| 6 | 1990 | 41 | |
| 7 | The efficacy and safety of paroxetine compared with placebo in outpatients with major depression. | 1992 | 21 |
| 8 | 1991 | 17 |
About Ira Fox
Ira Fox is a scholar working on Pharmacology, Experimental and Cognitive Psychology, Psychiatry and Mental health, Cognitive Neuroscience and Cellular and Molecular Neuroscience, having authored 8 papers that have together received 465 indexed citations. Recurring topics across this work include Treatment of Major Depression (7 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Attention Deficit Hyperactivity Disorder (2 papers), Memory and Neural Mechanisms (2 papers), Electroconvulsive Therapy Studies (2 papers), Opioid Use Disorder Treatment (1 paper), Mental Health Research Topics (1 paper) and Neurotransmitter Receptor Influence on Behavior (1 paper). The work is most often cited by research in Pharmacology (258 citations), Psychiatry and Mental health (157 citations), Experimental and Cognitive Psychology (144 citations), Biological Psychiatry (23 citations) and Cellular and Molecular Neuroscience (82 citations). Ira Fox has collaborated with scholars based in United States. Frequent co-authors include Karl Rickels, Edward E. Schweizer, Cathryn M. Clary, Charles C. Weise, Jay D. Amsterdam, Arthur P. Schless, David J. Greenblatt, Richard Balon, Robert Pohl and I Csanalosi. Their work appears in journals such as Pharmacopsychiatry, Journal of Clinical Psychopharmacology, Acta Psychiatrica Scandinavica, American Journal of Psychiatry and The British Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.